Trang chủ › Ung thư tuyến tiền liệt › Washington › Seattle
Thử nghiệm lâm sàng cho Ung thư tuyến tiền liệt tại Seattle, WA
44 nghiên cứu cho Ung thư tuyến tiền liệt đang tìm kiếm người tham gia tại các cơ sở ở Seattle và vùng lân cận (bán kính khoảng 30 dặm). Mở nghiên cứu để xem tiêu chí tham gia và cách liên hệ với đội ngũ nghiên cứu.
Văn bản nghiên cứu chính thức (Tiếng Anh)
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Đang tuyểnGiai đoạn 1
- Swedish Medical Center, Seattle
Precision-Based Genomics in Prostate Cancer
Đang tuyểnNghiên cứu quan sát
- University of Washington, Seattle
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
Đang tuyểnGiai đoạn 1
- Fred Hutchinson Cancer Center, Seattle
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
Đang tuyểnGiai đoạn 1
- Fred Hutchinson Cancer Research Center, Seattle
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Đang tuyểnGiai đoạn 2/3
- Fred Hutchinson Cancer Research Center, Seattle
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Đang tuyểnGiai đoạn 3
- Swedish Medical Center, Seattle
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Đang tuyểnGiai đoạn 2
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Đang tuyểnGiai đoạn 2
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Đang tuyểnGiai đoạn 3
- VA Puget Sound Health Care System ( Site 0054), Seattle
- Fred Hutchinson Cancer Center ( Site 0060), Seattle
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Đang tuyểnGiai đoạn 1/2
- University of Washington, Fred Hutchinson Cancer Center, Seattle
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
Đang tuyểnNghiên cứu quan sát
- University of Washington Medical Center, Seattle
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
Đang tuyểnGiai đoạn 2
- University of Washington, Seattle
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Đang tuyểnGiai đoạn 1
- Investigational Site Number: 400, Seattle
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Đang tuyểnGiai đoạn 3
- Fred Hutchinson Cancer Center, Seattle
- FHCC at Northwest Hospital, Seattle
- University of Washington Medical Center - Montlake, Seattle
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Đang tuyểnGiai đoạn 3
- Swedish Medical Center-First Hill, Seattle
Prostate Active Surveillance Study
Đang tuyểnNghiên cứu quan sát
- Veterans Affairs Puget Sound Health Care System, Seattle
- University of Washington, Seattle
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Đang tuyểnNghiên cứu quan sátChào đón tình nguyện viên khỏe mạnh
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- và 1 nữa
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Đang tuyểnGiai đoạn 2
- Swedish Medical Center-First Hill, Seattle
Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial
Đang tuyểnGiai đoạn 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
Đang tuyểnGiai đoạn 2
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
Đang tuyểnGiai đoạn 2
- University of Washington Medical Center, Seattle
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Đang tuyểnGiai đoạn 1
- Fred Hutchinson Cancer Center, Seattle
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
Đang tuyểnGiai đoạn 2
- Fred Hutchinson Cancer Center, Seattle
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Đang tuyểnGiai đoạn 3
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- và 4 nữa
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Đang tuyểnGiai đoạn 2
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
Đang tuyểnGiai đoạn 2
- Fred Hutchinson Cancer Center, Seattle
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
Đang tuyểnNghiên cứu quan sát
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
Đang tuyểnGiai đoạn 1/2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Đang tuyểnGiai đoạn 1
- Fred Hutchinson Cancer Center, Seattle
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
Đang tuyểnNghiên cứu quan sátChào đón tình nguyện viên khỏe mạnh
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
Đang tuyểnGiai đoạn 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
Đang tuyểnGiai đoạn 1
- Fred Hutchinson Cancer Center, Seattle
Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
Đang tuyểnGiai đoạn 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial
Đang tuyển
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Đang tuyểnGiai đoạn 3
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- và 4 nữa
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Đang tuyểnGiai đoạn 1
- University of Washington, Fred Hutchinson Cancer Center, Seattle
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
Đang tuyểnGiai đoạn 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Đang tuyểnGiai đoạn 2
- VA Puget Sound Health Care System, Seattle
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
Đang tuyểnNghiên cứu quan sátChào đón tình nguyện viên khỏe mạnh
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Đang tuyểnGiai đoạn 1/2
- Fred Hutchinson Cancer Center, Seattle
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Đang tuyểnGiai đoạn 1
- Fred Hutchinson Cancer Center, Seattle
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Đang tuyểnGiai đoạn 2
- Swedish Medical Center-Ballard Campus, Seattle
- FHCC South Lake Union, Seattle
- Fred Hutchinson Cancer Research Center, Seattle
- và 4 nữa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Đang tuyểnNghiên cứu quan sát
- Massive Bio SYNERGY-AI site, Seattle
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Đang tuyểnGiai đoạn 3
- FHCC South Lake Union, Seattle
- FHCC at Northwest Hospital, Seattle
- University of Washington Medical Center - Montlake, Seattle
Thử nghiệm cho Ung thư tuyến tiền liệt tại các thành phố khác
- New York City, NY103 nghiên cứu
- Houston, TX76 nghiên cứu
- Los Angeles, CA61 nghiên cứu
- Boston, MA60 nghiên cứu
- St. Louis, MO47 nghiên cứu
- San Francisco, CA45 nghiên cứu
- Chicago, IL45 nghiên cứu
- Philadelphia, PA44 nghiên cứu
- Nashville, TN43 nghiên cứu
- Baltimore, MD42 nghiên cứu
- Washington, DC38 nghiên cứu
- Dallas, TX36 nghiên cứu
Các nghiên cứu khác tại Seattle
- Ung thư phổi không tế bào nhỏ53 nghiên cứu
- Ung thư (mọi loại)50 nghiên cứu
- Bạch cầu tủy cấp40 nghiên cứu
- Ung thư vú40 nghiên cứu
- Ung thư di căn39 nghiên cứu
- Ung thư đại trực tràng34 nghiên cứu
- Ung thư phổi33 nghiên cứu
- Ung thư buồng trứng31 nghiên cứu
- Ung thư tụy22 nghiên cứu
- U tủy xương đa phát22 nghiên cứu
- Bạch cầu lympho cấp21 nghiên cứu
- Hội chứng rối loạn sinh tủy21 nghiên cứu
Nguồn dữ liệu từ ClinicalTrials.gov, cập nhật ngày 1 thg 10, 2026. Mỗi nghiên cứu có tiêu chí riêng; đội ngũ nghiên cứu sẽ quyết định ai đủ điều kiện tham gia.